Dr Reddy's starts CETP inhibitor study
October 10, 2011 | Monday | News
Dr Reddy’s Laboratories initiated dosing patients diagnosed with type
II dyslipidemia with DRL-17822. DRL-17822 is a selective, orally
bioavailable inhibitor of cholesteryl ester transfer protein (CETP),
for the treatment and prevention of dyslipidemia, atherosclerosis and
associated cardiovascular disease. The current study is being conducted
under a CTA in a number of countries in Europe.
The objective of the study is to evaluate the efficacy and safety of
DRL-17822 in patients with type-II dyslipidemia. This is a randomized,
double blind, placebo controlled, parallel group study in 160 subjects.
The primary outcome measure is to assess the elevation in HDL
cholesterol and reduction in LDL cholesterol from baseline to end of
treatment compared to placebo. Three doses (50, 150 and 300 mg) of
DRL-17822 given once daily for four weeks will be evaluated during this
study.
India, Canada to foster joint R&D
Under the Canada-India agreement for scientific and technological
cooperation, the governments of Canada and India have agreed to foster
joint research and development (R&D) projects by implementing
Ontario/India Collaborative Research Fund (CRF).
While the Indian side is being represented by the Department of
Biotechnology (DBT), Ministry of Science and Technology, Government of
India, the Canadian side is represented by the International Science
and Technology Partnerships Canada (ISTP), a non-governmental
organization selected by the Ministry of Research and Innovation (MRI),
Government of Ontario, Canada. The program is open to R&D projects
in all areas of biotechnology, including life sciences and medical
devices.
CSIR starts research on Ayurgenomics
The Council of Scientific and Industrial Research (CSIR) has
established a new line of research named Ayurgenomics, which is an
integrative approach of Ayurveda and Genomics, for the discovery of
predictive markers for preventive and personized medicine.
This was revealed by Minister of State for Science and Technology and
Earth Sciences Ashwani Kumar at the foundation day celebrations of CSIR
in New Delhi on September 26. While praising the efforts of CSIR in
this direction, the minister said, “This has given a novel molecular
framework for integration of these two disciplines and will accelerate
discovery of markers for predictive and personalized medicine. We need
to create new platforms for innovation, nurture them and make them
global.”
After the success of Open Source Drug Discovery (OSDD), the CSIR
launched Distributed Organic Chemical Synthesis Programme (DOCS) in
open source mode. The program has emerged as a new platform for
innovation in the domain of healthcare with the global partnership of
more than 4,500 researchers from over 100 countries as registered
participants.
DBT, EC collaborate for waste water
treatment solutions
The Department of Biotechnology (DBT), Government of India, and
European Commission have come together to support the development of
innovative biotechnological waste-water treatments for improved water
recycling for agriculture and to improve water use.
The objective of the pilot initiative is to support strategic
cooperation between India, the EU and member states for addressing more
effectively global societal challenge in water and bio resources
related issues. The project will develop applications for waste water
treatments, leading to a greater integration of researchers and
activities across India and the European Union. Through this program,
DBT intends to encourage multi-institutional networked program with
cross disciplinary partnerships The project funded under this activity
is an important building block of the pilot initiative for developing
EU and member states for strategic research and innovation agenda with
India.
The participation of industry, including SMEs, is expected to
contribute to bring a market-oriented innovation in this field in order
to address the social dimension of the project. A wide co-ordination of
research activities in the topic area between India and the EU, which
are both major players in these fields, will contribute to step up the
India-EU collaboration in scope and scale. The collaborative project
includes the large-scale integrating project targeted at small and
medium scale enterprises.
